ArticleContemporary clinical dentistry
Differential Expression of Salivary Transcriptomic Biomarkers SAT1 and PSMB2 in Type 2 Diabetes Mellitus: A Case-Control Study.
Article in Contemporary clinical dentistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Type 2 diabetes mellitus (T2DM) is the most common underdiagnosed metabolic disease due to lack of recognizable symptoms in the early phase. T2DM often goes undetected for years, leading to high rates of complications and mortality. RNA signatures in saliva could serve as valid, noninvasive biomarker for the detection of T2DM with high sensitivity and specificity. Aim: To analyze the relative gene expression of salivary transcriptomic biomarkers SAT1 and PSMB2 in individuals with T2DM. Settings and Design: This case-control study included two groups: age- and sex-matched T2DM patients and healthy controls, with 50 participants in each group. Subjects and Methods: Unstimulated saliva samples were collected from all participants. Relative gene expression levels of salivary transcriptomic biomarkers, such as SAT1 and PSMB2 were analyzed using real-time polymerase chain reaction. The messenger RNA expression levels and fold changes were calculated using 2-ΔΔCT method. Statistical Analysis: Student's Results: The SAT1 gene was found to be downregulated by 54%, with a fold change of 0.46 in T2DM compared to controls, while PSMB2 was downregulated in T2DM when compared to healthy controls. Among the two biomarkers, PSMB2 showed a statistically significant difference ( Conclusion: Our study demonstrated that analysis of the genetic expression of salivary transcriptomic biomarkers SAT1 and PSMB2 genes in the saliva of T2DM patients might help in the development of a noninvasive early diagnostic aid to facilitate early intervention of T2DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.